Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients

Colorectal Cancer (CRC) is one of the most common cancers accounting for 1.8 million new cases worldwide every year. Therefore, the identification of new potential therapeutic targets represents a continuous challenge to improve survival and quality of CRC patient’s life. We performed a microarray a...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Rosa, Michelino, Di Cataldo, Antonio, Broggi, Giuseppe, Caltabiano, Rosario, Tibullo, Daniele, Castrogiovanni, Paola, Imbesi, Rosa, Lanteri, Raffaele, Salomone, Federico, Raciti, Giuseppina, Li Volti, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883247/
https://www.ncbi.nlm.nih.gov/pubmed/36707698
http://dx.doi.org/10.1038/s41598-023-28450-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883247/
https://www.ncbi.nlm.nih.gov/pubmed/36707698
http://dx.doi.org/10.1038/s41598-023-28450-1

Ejemplares similares